Vestal Point Capital, LP Portfolio Holdings
Vestal Point Capital, LP
- $1.69 Trillion
- Q4 2024
Vestal Point Capital, LP has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $1.69 Trillion distributed in 73 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Jazz Pharmaceuticals PLC with a value of $120B, Cytokinetics Inc with a value of $111B, Merck & Co., Inc. with a value of $79.6B, Ascendis Pharma A/S with a value of $71.6B, and Ultragenyx Pharmaceutical Inc. with a value of $63.1B.
Examining the 13F form we can see an increase of $368B in the current position value, from $1.32T to 1.69T.
Vestal Point Capital, LP is based out at New York, NY
Below you can find more details about Vestal Point Capital, LP portfolio as well as his latest detailed transactions.